Table 4.
Multivariate analysis: prognosis prediction score and clinical and therapeutic variables associated with overall survival in patients with grade 4 glioma
| Variable | Subgroup | Entire series (n = 32) | ||
|---|---|---|---|---|
| Hazard ratio | 95% CI | P | ||
| Z 1 | Continuous variable | 1.34 | 1.03–1.77 | 0.026 |
| Z 2 | Continuous variable | 1.48 | 0.95–2.38 | 0.081 |
| MGMT IHC | Positive/Negative | 1.72 | 0.70–4.30 | 0.228 |
| Age (years) | ≥60, <60 | 2.22 | 0.95–5.37 | 0.065 |
| KPS | ≥70, <70 | 2.76 | 0.88–8.50 | 0.078 |
CI, confidence interval; IHC, immunohistochemistry; MGMT, anti‐O6‐methylguanine‐methyltransferase.